Linda F. Hogle
Title: Professor of Medical Social Sciences, Emerita
Interests: Stem cell and tissue engineering policy and ethics; socio-cultural,
political and ethical issues in emerging biomedical engineering
technologies; transnational issues in governance of novel technologies.
Office:Room 1440, Medical Sciences Center
Affiliations: Robert & Jean Holtz Center for Science and Technology Studies (former
director); Stem Cell & Regenerative Medicine Center (Executive Committee);
Cardiovascular Research Center; Neuroscience and Public Policy Program;
Center for Global Health; European Studies Center of Excellence; Visual
Culture Center; Center for Biomedicine and Society, King's College London
Wisconsin Institute for Discovery - https://wid.wisc.edu/people/linda-hogle/
Stem Cell & Regenerative Medicine Center - https://stemcells.wisc.edu/staff/hogle-linda-f/
Ph.D., University of California, San Francisco, and University of California, Berkeley, Medical Anthropology, 1996
Linda F. Hogle (Ed.), Regenerative Medicine Ethics: Governing Research and Knowledge Practices (Springer, 2014).
Linda F. Hogle, Recovering the Nation's Body: Cultural Memory, Medicine, and the Politics of Redemption (Rutgers University Press, 1999).
Selected Book Sections
"Intersections of Technological and Regulatory Zones in Regenerative Medicine" section in Aditya Bharadwaj, ed., Global Perspectives on Stem Cell Technologies (Palgrave Macmillan, 2018).
"The Ethics and Politics of Infrastructures: Creating the Conditions of Possibility for Big Data in Medicine" section in Brent Daniel Mittelstadt and Luciano Floridi, eds., The Ethics of Biomedical Big Data (Springer, 2016).
"Emerging Medical Technologies" section in Edward J. Hackett, Olga Amsterdamska, Michael Lynch, and Judy Wajcman, eds., The Handbook of Science and Technology Studies, Third Edition (The MIT Press, 2007).
"Medical Technology" section in Sal Restivo, ed., Science, Technology, and Society: An Encyclopedia (Oxford University Press, 2005).
Linda F. Hogle and Amritava Das, "The social production of evidence: regenerative medicine and the 21st Century Cures Act," Regenerative Medicine 12:6 (2017), 581-586. Special issue on social and ethical issues of regenerative medicine.
Linda F. Hogle, "Data-intensive resourcing in healthcare," BioSocieties 11:3 (2016), 372-393. Special issue on Big Data.
Linda F. Hogle, "Characterizing Human Embryonic Stem Cells: Biological and Social Markers of Identity," Medical Anthropology Quarterly 24:4 (2010), 433-450.
Linda F. Hogle, "Pragmatic Objectivity and the Standardization of Engineered Tissues," Social Studies of Science 39:5 (2009), 1-26.
Linda F. Hogle, "Science, Ethics and the 'Problems' of Governing Nanotechnologies," Journal of Law, Medicine & Ethics 37:4 (2009), 749–758.
Raval, A., T. Kamp, and L. Hogle, "Cellular Therapies for Heart Disease: Unveiling the Ethical and Public Policy Challenges," Journal of Molecular Cellular Cardiology 45:4 (2008), 593-601.
Greely, H., Cho, M., Hogle, L.F., and Satz, D., "Thinking about the Human Neuron Mouse," American Journal of Bioethics-Neuroethics 7:5 (2007), 27-34.
MHB 526/726: Medical Technology and the Body (Syllabus)
MHB 559: Issues in Innovative Medicine: Regenerative Medicine and Nanobiotechnology (Syllabus)
MHB 728: Biomedical Ethics and Society (Syllabus)
MHB 734: Topics in Biomedical Ethics: "Brain Matters" (Syllabus)
STS 903: Interdisciplinary Science and the Modern University